← back to search

Bing Yu

Academy of Medical Sciences · GB
Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Amyotrophic Lateral Sclerosis Research, and Neurogenetic and Muscular Disorders Research.
h-index
47
citations
8,344
works
373
NIH funding
primary concept
email

Recent publications

Probiotic administration aggravates dextran sulfate sodium salt-induced inflammation and intestinal epithelium disruption in weaned pig
Animal Microbiome 2025cited by 4position: middledoi
Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing.
2024cited by 2position: contributordoi
Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8 <sup>+</sup> T cell metabolic fitness and function in tumors
Science Immunology 2023cited by 85position: middledoi
MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR
Cancer Communications 2023cited by 26position: middledoi
Metabolomic Signatures of Sedentary Behavior and Cardiometabolic Traits in US Hispanics/Latinos: Results from HCHS/SOL
Medicine & Science in Sports & Exercise 2023cited by 7position: middledoi
Structural and functional characterization of multiple myeloma associated cytoplasmic poly(A) polymerase FAM46C
Cancer Communications 2021cited by 17position: middledoi
Molecular patterns in salivary duct carcinoma identify prognostic subgroups
Modern Pathology 2020cited by 31position: middledoi
FAM46B is a prokaryotic-like cytoplasmic poly(A) polymerase essential in human embryonic stem cells
Nucleic Acids Research 2020cited by 23position: middledoi
Molecular patterns in salivary duct carcinoma identify prognostic subgroups.
2020cited by 23position: contributordoi
Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset
Nature Communications 2019cited by 165position: middledoi
Is high-risk cutaneous squamous cell carcinoma of the head and neck a suitable candidate for current targeted therapies?
Journal of Clinical Pathology 2019cited by 6position: lastdoi
Structure of Schlafen13 reveals a new class of tRNA/rRNA- targeting RNase engaged in translational control
Nature Communications 2018cited by 130position: middledoi
Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases
Cancer Biology & Therapy 2018cited by 46position: middledoi
[Association between hyponatremia and hemodynamic and prognosis in patients with intermediate-risk acute pulmonary embolism].
PubMed 2018cited by 3position: middledoi
MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion
Nature 2017cited by 327position: middledoi
Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: A multi‐institutional study
Journal of Surgical Oncology 2017cited by 85position: middledoi
Reviewing the genetic alterations in high‐risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets
Head & Neck 2017cited by 60position: middledoi
Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma
Modern Pathology 2017cited by 48position: middledoi
Abstract: Interpositional Arthroplasty by Temporalis Fascia Flap and Galea Aponeurotica Combined with Distraction Osteogenesis: A Modified Method in Treatment of Adult Patients with TMJ Ankylosis and Mandibular Dysplasia
Plastic & Reconstructive Surgery Global Open 2017cited by 0position: middledoi
EGFR–Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase Inhibitors
Journal of Thoracic Oncology 2016cited by 79position: middledoi
Preoperative nomogram for identifying invasive pulmonary adenocarcinoma in patients with pure ground-glass nodule: A multi-institutional study
Oncotarget 2016cited by 67position: middledoi
Screening for <i><scp>ROS</scp>1</i> gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with <scp>FISH</scp> confirmation is an effective method to identify this rare target
Histopathology 2016cited by 63position: middledoi
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma
Lung Cancer 2015cited by 302position: middledoi
Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations
Head & Neck 2015cited by 84position: middledoi
Salivary duct carcinoma: clinicopathologic features, morphologic spectrum and somatic mutations
2015cited by 64position: middle
Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS
Scientific Reports 2015cited by 60position: middledoi
Genomes of the rice pest brown planthopper and its endosymbionts reveal complex complementary contributions for host adaptation
Genome biology 2014cited by 455position: middledoi
Genomic signatures of near-extinction and rebirth of the crested ibis and other endangered bird species
Genome biology 2014cited by 150position: middledoi
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma
British Journal of Cancer 2014cited by 105position: middledoi
Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (<i>PTPN11</i>)
Journal of Medicinal Chemistry 2013cited by 71position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ruta Gupta · Guru Gobind Singh Indraprastha University6 papers (2015–2020)Sandra O’Toole · The University of Sydney5 papers (2014–2016)Song Gao · Sun Yat-sen University5 papers (2017–2023)Christina Selinger · Royal College of Pathologists of Australasia5 papers (2015–2016)Jian-Xiong Feng · Sun Yat-sen University4 papers (2017–2023)Wendy A. Cooper · Royal Prince Alfred Hospital4 papers (2014–2016)Michael Boyer · Chris O’Brien Lifehouse4 papers (2015–2016)Marie Ranson · University of Manchester3 papers (2017–2019) · 3 papers (2017–2020)Bruce Ashford · University of Wollongong3 papers (2017–2019)Lisa G. Horvath · The University of Sydney3 papers (2015–2016)Yang Chen · RE Hydrogen (United Kingdom)3 papers (2017–2021)Jonathan R. Clark · UNSW Sydney3 papers (2017–2019)N. Gopalakrishna Iyer · Duke-NUS Medical School3 papers (2017–2019)Jonathan R. Clark · The University of Sydney3 papers (2015–2020)Peter P. Luk · UNSW Sydney3 papers (2015–2020)Matthew Weicai Lee · University of Sydney2 papers (2017–2019)Weirong Shi · Nantong University2 papers (2016–2017) · 2 papers (2016–2017)David C. Chan · California Institute of Technology2 papers (2017–2019)